Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells
暂无分享,去创建一个
M. Lim | Z. Zakaria | Kamal Shaik Fakiruddin | P. Baharuddin | N. Fakharuzi | Nurul Ain Nasim M Yusof
[1] Ying He,et al. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation , 2014, Molecular medicine reports.
[2] M. Lim,et al. Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells , 2014, Cancer Cell International.
[3] Qutayba Hamid,et al. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation. , 2014, Toxicology and applied pharmacology.
[4] M. Soleimani,et al. Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases , 2014, Cell journal.
[5] Wei Zhou,et al. Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds. , 2014, Tissue engineering. Part A.
[6] Zhenghui Wang,et al. Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[7] F. Menaa,et al. Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice. , 2014, Human gene therapy.
[8] A. Jahanian-Najafabadi,et al. Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.
[9] Shikha Sharma,et al. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. , 2014, The international journal of biochemistry & cell biology.
[10] H. Trivedi,et al. In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1 , 2014, Cytotechnology.
[11] J. Solano,et al. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia. , 2013, Hematology/oncology and stem cell therapy.
[12] R. Zhao,et al. Stepwise differentiation of human adipose-derived mesenchymal stem cells toward definitive endoderm and pancreatic progenitor cells by mimicking pancreatic development in vivo. , 2013, Stem cells and development.
[13] E. Y. Kim,et al. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5 , 2013, Molecules and cells.
[14] L. Ferroni,et al. Potential for neural differentiation of mesenchymal stem cells. , 2012, Advances in biochemical engineering/biotechnology.
[15] J. Burns,et al. MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential. , 2013, Advances in biochemical engineering/biotechnology.
[16] K. Martin,et al. Tart cherry juice induces differential dose-dependent effects on apoptosis, but not cellular proliferation, in MCF-7 human breast cancer cells. , 2012, Journal of medicinal food.
[17] G. Warnock,et al. Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. , 2011, World journal of stem cells.
[18] M. J. Mahon,et al. Vectors bicistronically linking a gene of interest to the SV40 large T antigen in combination with the SV40 origin of replication enhance transient protein expression and luciferase reporter activity. , 2011, BioTechniques.
[19] G. Warnock,et al. Potential implications of mesenchymal stem cells in cancer therapy. , 2011, Cancer letters.
[20] M. Andreeff,et al. Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.
[21] Ralph Weissleder,et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.
[22] C. Hao,et al. TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. , 2009, Reviews on recent clinical trials.
[23] J. Hengstler,et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo , 2008, Gut.
[24] J. Stagg. Mesenchymal Stem Cells in Cancer , 2008, Stem Cell Reviews.
[25] H. Rehman,et al. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest , 2007, Cancer biology & therapy.
[26] T. Ochiya,et al. Adipose tissue‐derived mesenchymal stem cells as a source of human hepatocytes , 2007, Hepatology.
[27] C. Dani,et al. Nucleofection Is a Valuable Transfection Method for Transient and Stable Transgene Expression in Adipose Tissue‐Derived Stem Cells , 2007, Stem cells.
[28] M. Baccarani,et al. Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells , 2006, Stem cells.
[29] R. Gay,et al. Nucleofection: a new, highly efficient transfection method for primary human keratinocytes * , 2005, Experimental Dermatology.
[30] Min-Jeong Seo,et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. , 2005, Biochemical and biophysical research communications.
[31] G. Mills,et al. Mesenchymal Stem Cells Promote Survival of Leukemic Cells Via Integrin-Linked Kinase (ILK)-Dependent Akt and STAT3 Activation: Implications for Leukemia Therapy. , 2004 .
[32] H. Tsuda,et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.
[33] Susana Castro-Obregon,et al. New non-viral method for gene transfer into primary cells. , 2004, Methods.
[34] F. Barry,et al. Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.
[35] X. Hao,et al. Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis , 2003, Apoptosis.
[36] A. Ashkenazi,et al. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. , 2003, Cytokine & growth factor reviews.
[37] Mark A. Kay,et al. Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.
[38] W. Wilkison,et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. , 2002, Biochemical and biophysical research communications.
[39] W I Wood,et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.